Document:

Exhibit 10.25

 

 

February 16, 2012

 

Mr. John Monson

 

Dear John,

 

I am pleased to offer you a position with MoSys, Inc. (the “Company”) as Vice President of Product Marketing, an officer of the Company, subject to ratification by the Company’s board of directors.  This offer letter (the “Agreement”) sets forth the terms and conditions of the Company’s offer of employment. This is intended to be a binding agreement, and if the terms contained in this Agreement are acceptable to you, please acknowledge your acceptance by signing in the signature block, below. The Company’s offer of employment is conditioned upon: (I) your presenting satisfactory evidence of your authorization to work in the United States and your identity sufficient to allow the Company to complete the I-9 form required by law within three business days of the Commencement of your employment with the Company; (2) your consent to, and satisfactory completion of a reference and background check; and (3) your execution of the Company’s standard form of Employment, Confidential Information and Invention Assignment agreement.

 

Your primary responsibilities will be those normally associated with the position of Vice President of Product Marketing, an exempt position, as well as such other duties as may from time to time be assigned to you.  While employed by the Company, you may not work as an employee or consultant of any other organization or engage in any other activities which conflict or interfere with your obligations to the Company, without the express prior written approval of the Chief Executive Officer of the Company.  It is understood that you will not be employed by any other person or organization when you commence employment with the Company.

 

You will report to the Chief Executive Officer. Your semi-monthly compensation will be $8958.33 dollars and annualized, is equal to $215,000.00 a year. Your compensation will be paid in accordance with the Company’s normal payroll procedures and will be subject to applicable withholding required by law or as authorized by you.

 

Upon approval of the compensation committee of the board of directors, you will be granted an option to purchase 175,000 shares of the Company’s common stock. The option will vest 25% at the end of one year of employment and 2.0833% per month thereafter. The per share exercise price of the option shall be the fair market value of the Company’s common stock on the date of grant. This option will be granted as a new employment inducement grant under the NASDAQ Marketplace Rules and not pursuant to the Company’s existing option plan.

 

You will also be eligible to participate, subject to the generally applicable terms and conditions of the plan or program in question and the determination of any committee administering such plan or program, in the Company’s employee benefit plans and programs, including standard major medical, dental, life, disability and vision insurance benefits, flexible benefit plan, paid holidays, personal time off (PTO), Employee Stock Purchase Plan, and the 401(k)  plan. Please consult the terms of those plans, which govern your eligibility and terms,

 

MoSys, Inc. · 3301 Olcott Street, Santa Clara, CA  95054 · Tel: 408.418.7500 Fax: 408.418-7501 · www.mosys.com

 

 

and/or contact the Company’s Human Resources Department.  You will be reimbursed on a regular basis for reasonable, necessary and properly documented business and travel expenses incurred for the purpose of conducting the Company’s business, in accordance with Company policy.

 

You should be aware that your employment with the Company is for no specified period and constitutes at will employment.  As a result, you are free to resign at any time, for any reason or for no reason.  Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause.

 

MANDATORY ARBITRATION AND WAIVER OF RIGHT TO JURY TRIAL: You agree that any dispute arising out of or related to your employment, including termination of your employment, with the Company shall be resolved only by an arbitrator through final and binding arbitration pursuant to the then current Employment Arbitration Rules of the J AMS (Judicial Arbitration & Mediation Services) (available at www.jamsadr.com) or, at the Parties’ option, under the American Arbitration Association‘s National Rules for the Resolution of Employment Disputes (available at www.aadr.org), and not by way of court or jury trial. Attached for your reference is a copy of the current JAMS Employment Arbitration Rules, which are also available on JAMS’ website.  Please acknowledge your receipt of the JAMS Employment Arbitration Rules:

 

You and the Company agree d1at any dispute regarding any aspect of this Agreement, including the confidentiality provisions,  shall be submitted exclusively to final and binding arbitration before a mutually agreed upon arbitrator in accordance with the Federal Arbitration Act (“FAA”), 9 U.S.C. §§ I, et seq. In the event that the FAA does not apply for any reason, then the arbitration will proceed pursuant to the California Arbitration Act, California Code of Civil Procedure §§ 1280, et seq. The arbitrator shall be empowered to award any appropriate relief, including remedies at law, in equity or injunctive relief. The arbitrator may award any pa11y any remedy to which that party is entitled under applicable law, but such remedies shall be limited to those that would be available to a party in a court of law for the claims presented to and decided by the arbitrator.  The arbitrator will issue a decision or award in writing, stating the essential findings of fact and conclusions of law. The location of the arbitration proceeding shall be in the general geographical vicinity of the place where you last worked for the Company, unless each party to the arbitration agrees in writing otherwise.  You and the Company agree that this arbitration shall be the exclusive means of resolving any dispute under this Agreement and that no other action will be brought by them in any court or other forum.  If you and the Company cannot agree on an arbitrator, then an arbitrator will be selected using the alternate striking method from a list of five (5) neutral arbitrators provided  by the applicable J AMS Rule.  Each Party will pay the fees for their own counsel, subject to any remedies to which that party may later be entitled under applicable law. However, in all cases where required by applicable law, the Company will pay the arbitrator’s fees and the arbitration costs.  If und er applicable law the Company is not required to pay the arbitrator’s  fees and the arbitration costs, then such fees and costs will be apportioned equally between each set of adverse Parties.

 

 

Except as may be permitted or required by law, neither a party nor an arbitrator may disclose the existence, content, or results of any arbitration hereunder without the prior written consent of all parties. A court of competent jurisdiction shall have the authority to enter a judgment upon the award made pursuant to the arbitration. Claims may be brought before an administrative agency, but only to the extent applicable law permits access to such an agency notwithstanding the existence of an agreement to arbitrate. However, there will be no right or authority for any dispute to be brought, heard or arbitrated as a class or collective action.

 

To indicate your acceptance of the Company’s offer, please sign and date this letter in the space provided below and return it to the Human Resources Department (Tammy Carr).  This offer will expire on February 24, 2012. This Agreement, along with the applicable stock option agreement between you and the Company, together with the Company’s standard employment policies and procedures in effect from time to time, constitutes the entire terms of your employment with the Company and supersedes all prior representations or agreements, whether written or oral. This Agreement is to be governed by California law, without regard to any conflicts of law. To the extent that any of the terms of this Agreement or any of the foregoing agreements conflict with the Company’s standard employment policies and procedures in effect from time to time, the former shall govern. This Agreement may not be modified or amended except by a written agreement signed by the Chief Executive Officer of the Company and you.

 

We believe that you can make a great contribution to the Company, and we all look forward to working with you.

 

	
 
    	
Sincerely,
    
	
 
    	
 
    
	
 
    	
/s/   Len Perham
    
	
 
    	
Len   Perham
    
	
 
    	
Chief   Executive Officer
    

 

 

ACCEPTED AND AGREED TO

This 20 day of February, 2012

 

	
Start date:
    	
Feb.   21, 2012
    	
 
    
	
 
    	
 
    
	
 
    	
/s/   John Monson
    
	
 
    	
John   MonsonExhibit 4.1

 

SECOND SUPPLEMENTAL INDENTURE

 

 

SECOND SUPPLEMENTAL INDENTURE

dated as of March 11, 2014

 

with respect to the

 

INDENTURE

dated as of October 21, 2010

 

(relating to Senior Secured Notes due 2017)

 

among

 

CET 21 SPOL. S R.O.

 

as Issuer,

 

CENTRAL EUROPEAN MEDIA ENTERPRISES LTD.,

 

CENTRAL EUROPEAN MEDIA ENTERPRISES N.V.,

 

CME MEDIA ENTERPRISES B.V.,

 

CME INVESTMENTS B.V.,

 

CME SLOVAK HOLDINGS B.V.

 

and

 

MARKÍZA-SLOVAKIA, SPOL. S R.O.

 

as Guarantors,

 

CITIBANK, N.A., LONDON BRANCH

 

as Trustee,

 

CITIBANK, N.A., LONDON BRANCH

 

as Paying Agent and Transfer Agent,

 

and

 

CITIGROUP GLOBAL MARKETS DEUTSCHLAND AG,

 

as Registrar

 

A-2

 

SECOND SUPPLEMENTAL INDENTURE, dated as of March 11, 2014 (this “Second Supplemental Indenture”), among (i) CET 21 spol. s r.o. (together with its successors and assigns, the “Issuer”), (ii) Central European Media Enterprises Ltd. (“CME”), (iii) Central European Media Enterprises N.V., (iv) CME Media Enterprises B.V., (v) CME Investments B.V., (vi) CME Slovak Holdings B.V., (vii) MARKÍZA-SLOVAKIA, spol. s r.o. (collectively, the “Guarantors”) and (viii) Citibank, N.A., London Branch, as Trustee, under the Indenture referred to below.

 

RECITALS

 

WHEREAS, the Issuer, the Guarantors, the Trustee and the other parties thereto have executed and delivered an Indenture, dated as of October 21, 2010, as amended and supplemented by the Supplemental Indenture, dated as of December 18, 2012 (as so amended and supplemented and as may be further amended, supplemented, waived or otherwise modified, the “Indenture”), providing for the creation and issuance of the Senior Secured Notes due 2017 of the Issuer (the “Notes”);

 

WHEREAS, Section 9.2 of the Indenture provides that the Indenture may be amended with the consent of the holders of a majority in principal amount of the Notes then outstanding; provided that certain amendments may not be affected without the consent of each holder of the Notes affected;

 

WHEREAS, the Issuer and the Guarantors desire to amend the Indenture so as to permit CME, Central European Media Enterprises N.V., a company incorporated under the laws of the former Netherlands Antilles and existing under the laws of Curaçao (“CME NV”), and CME Media Enterprises B.V., a private limited liability company incorporated and existing under the laws of the Netherlands (“CME BV”), the flexibility to incur (i) the Transaction Related Indebtedness (as defined herein) to enable CME to refinance in full its €272,972,000 aggregate principal amount of 11.625% Senior Notes due 2016 (the “2016 Notes”) and for general corporate purposes and refinancing indebtedness in respect thereof, (ii) additional Indebtedness under the Indenture in an amount up to €40.0 million (exclusive of paid-in-kind interest) for general corporate purposes and (iii) the Time Warner Revolving Credit Facility (as defined herein), and to permit all such additional Indebtedness to be secured by the CME Collateral;

 

WHEREAS, the Issuer and the Guarantors desire to (i) modify the last sentence of Section 6.2 of the Indenture to provide for the Trustee’s obligation to automatically accelerate all amounts owing in respect of the Notes and declare them to be immediately due and payable and to cooperate with the other secured parties to exercise enforcement rights in connection with any other creditor party to the Existing Intercreditor Agreement exercising its enforcement rights against the CME Collateral and (ii) authorize the Trustee to enter into one or more related amendments to the Existing Intercreditor Agreement;

 

WHEREAS, the Issuer and the Guarantors desire and have requested the Trustee to join with them in entering into this Second Supplemental Indenture as permitted by Section 9.2 of the Indenture for the purpose of amending the Indenture in certain respects;

 

WHEREAS, the Issuer and the Guarantors have received the consent of the holders of a majority in principal amount of the Notes outstanding and have satisfied all other conditions precedent, if any, provided under the Indenture to enable the Issuer, the Guarantors and the Trustee to enter into this Second Supplemental Indenture, all as certified by an Officers’ Certificate, delivered to the Trustee simultaneously with the execution and delivery of this Second Supplemental Indenture as contemplated by Sections 9.5 and 12.2 of the Indenture;

 

WHEREAS, the Issuer has delivered to the Trustee simultaneously with the execution and delivery of this Second Supplemental Indenture an Opinion of Counsel relating to this Second Supplemental Indenture as contemplated by Sections 9.5 and 12.2 of the Indenture; and

 

A-3

 

WHEREAS, the Issuer and the Guarantors have duly authorized the execution and delivery of this Second Supplemental Indenture and have done all things necessary to make this Second Supplemental Indenture a valid agreement in accordance with its terms.

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Guarantors and the Trustee mutually covenant and agree for the equal and ratable benefit of the holders of the Notes as follows:

 

ARTICLE I

 

Definitions

 

SECTION 1.1  Defined Terms.  Terms defined in the Indenture and not otherwise defined in this Second Supplemental Indenture have the meanings assigned to them in the Indenture. The words “herein,” “hereof” and “hereby” and other words of similar import used in this Second Supplemental Indenture refer to this Second Supplemental Indenture as a whole and not to any particular section hereof.

 

ARTICLE II

 

SECTION 2.1  Amendment to Section 1.1 of the Indenture.  The following definitions are hereby added to Section 1.1 of the Indenture in a manner that maintains alphabetical order:

 

““Backstop Commitment” shall have the meaning set forth in the Framework Agreement.”

 

““Framework Agreement” means that certain framework agreement, dated as of February 28, 2014, among CME, TW BV and Time Warner (but excluding any amendment to or waiver in respect of such agreement).”

 

““Rights Offering” shall have the meaning set forth in the Framework Agreement.”

 

““Time Warner” means Time Warner Inc. and/or one or more of its affiliates.”

 

““Time Warner Revolving Credit Facility” means that certain revolving credit agreement, among CME, as borrower, CME BV and CME NV, as original guarantors, lenders party thereto from time to time and Time Warner, as administrative agent, as such facility may be amended, restated, modified, renewed, refunded, replaced, restructured or refinanced in whole or in part from time to time.”

 

““Transaction Related Indebtedness” means (i) Indebtedness under that certain term loan credit facility (the “Time Warner Term Loan Credit Facility” and the loans outstanding thereunder, the “Term Loans”) among CME, as borrower, CME BV and CME NV, as original guarantors, the lenders party thereto from time to time and Time Warner, as administrative agent, as such facility may be amended, restated, modified, renewed, or restructured from time to time, or refinanced from time to time to the extent such refinancing would, if the proceeds of such refinancing had been used, in lieu of the proceeds of such Time Warner Term Loan Credit Facility, to refinance the 2009 Notes, constitute Refinancing Indebtedness in respect of the 2009 Notes, pursuant to which Time Warner will make a Term Loan to CME in the aggregate principal amount of up to the sum of (A) the U.S. Dollar equivalent of € 288,838,498 (as of the Business Day immediately prior to May 29, 2014 using the Euro/U.S. Dollar spot exchange rate published in the Wall Street Journal) (the “Refinancing Portion of the Term Loan”) plus (B) $30.0 million, and (ii) without duplication of (i), indebtedness comprised of Senior Secured Note due 2017 (the “2017 PIK Notes”) to be issued by CME in connection with the Rights Offering, in each case as such Indebtedness may be amended or modified from time to time or refinanced from time to time to the extent such refinancing would constitute Refinancing Indebtedness in respect thereof.”

 

““TW BW” means Time Warner Media Holdings B.V.”

 

A-4

 

““Unit Private Placement” shall have the meaning set forth in the Framework Agreement.”

 

SECTION 2.2  Amendment to Section 1.1 of the Indenture.

 

The definition of “Permitted Collateral Liens” in the Indenture is amended by deleting subclause (B)(ii) in its entirety and replacing it with the foregoing:

 

“(ii) to secure Indebtedness of CME or any Restricted Subsidiary of CME, which Indebtedness is permitted to be Incurred under clauses (1), (3), (11), (13) or (14) of Section 4.3(b), and any Refinancing Indebtedness in respect of such Indebtedness; provided that the lenders of such Indebtedness or their duly authorized representatives become party to the Existing Intercreditor Agreement; and”

 

SECTION 2.3  Amendment to Section 4.3(b) of the Indenture.

 

(a)                                 Section 4.3(b)(11) of the Indenture shall be amended by deleting it in its entirety and replacing it with the following:

 

“(11) in addition to the items referred to in clauses (1) through (10) above and (12) through (14) below, Indebtedness of CME and its Restricted Subsidiaries in an aggregate outstanding principal amount which, when taken together with the principal amount of all other Indebtedness Incurred pursuant to this clause (11) and then outstanding, will not exceed €40.0 million at any time outstanding; provided that for the purposes of determining the amount of Indebtedness outstanding pursuant to this clause (11), such Indebtedness shall exclude interest paid in the form of an increase in the outstanding principal amount of such Indebtedness;”

 

(b)                                 Section 4.3(b) of the Indenture shall be amended by deleting the “.” at the end of subclause (12) and replacing it with a “;” and adding the following subsections (13) and (14) after subsection (12) of Section 4.3(b):

 

“(13) in addition to the items referred to in clauses (1) through (12) above and (14) below, Indebtedness of CME, CME NV and CME BV in an aggregate outstanding principal amount which, when taken together with the principal amount of all other Indebtedness Incurred pursuant to this clause (13) and then outstanding, will not exceed €40.0 million at any time outstanding plus any Transaction Related Indebtedness to the extent such Indebtedness Incurred pursuant to this clause (13) could not qualify as Refinancing Indebtedness; provided that for the purposes of determining the amount of Indebtedness outstanding pursuant to this clause (13), such Indebtedness shall exclude interest paid in the form of an increase in the outstanding principal amount of such Indebtedness or an issuance of additional 2017 PIK Notes to satisfy interest payable in respect thereof; and

 

(14) Indebtedness of CME, CME NV and CME BV Incurred under one or more credit facilities in an aggregate principal amount up to $115.0 million at any time outstanding, which shall initially consist of the Time Warner Revolving Credit Facility; provided that for the purposes of determining the amount of Indebtedness outstanding pursuant to this clause (14), such Indebtedness shall exclude interest paid in the form of an increase in the outstanding principal amount of such Indebtedness.”

 

SECTION 2.4  Amendment to Section 6.2 of the Indenture; Authorization to Amend Existing Intercreditor Agreement.

 

(a)                                 Section 6.2 of the Indenture shall be amended by deleting the last sentence in its entirety and replacing it with the following:

 

“Pursuant to the terms of the Existing Intercreditor Agreement, in the event that any indebtedness that is a beneficiary of the Existing Intercreditor Agreement delivers an

 

A-5

 

Enforcement Notice, the other indebtedness benefitting from the Existing Intercreditor Agreement (including the Notes) is required to be and shall be automatically accelerated.”

 

(b)                                 The Trustee is authorized and directed to enter into one or more deeds of amendment to the Existing Intercreditor Agreement not inconsistent with the description thereof contained in the Consent Solicitation Statement dated February 28, 2014 pursuant to which the Issuer and the Guarantors solicited the consent of the holders of a majority in principal amount of the Notes outstanding to enable the Issuer, the Guarantors and the Trustee to enter into this Second Supplemental Indenture.

 

ARTICLE III

 

Miscellaneous

 

SECTION 3.1  Parties.  Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or corporation, other than the holders of the Notes and the Trustee, any legal or equitable right, remedy or claim under or in respect of this Second Supplemental Indenture or the Indenture or any provision herein or therein contained.

 

SECTION 3.2  Governing Law.  This Second Supplemental Indenture shall be governed by the laws of the State of New York.

 

SECTION 3.3  Severability Clause.  In case any provision in this Second Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity, illegality or unenforceability.

 

SECTION 3.4  Ratification of Indenture; Second Supplemental Indentures Part of Indenture.  Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Second Supplemental Indenture shall form a part of the Indenture for all purposes and the Indenture is deemed to be modified as provided in this Second Supplemental Indenture, and every holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby. The Trustee shall not be responsible in any manner whatsoever for or in respect of the adequacy, the validity or sufficiency of this Second Supplemental Indenture or for or in any respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the Guarantors.

 

SECTION 3.5  Counterparts.  The parties hereto may sign one or more copies of this Second Supplemental Indenture in counterparts, all of which together shall constitute one and the same agreement.

 

SECTION 3.6  Headings.  The headings of the Articles and the sections in this Second Supplemental Indenture are for convenience of reference only and shall not be deemed to alter or affect the meaning or interpretation of any provisions hereof.

 

SECTION 3.7  Successors.  All covenants and agreements in this Second Supplemental Indenture by the parties hereto shall bind their successors and assigns, whether so expressed or not.

 

SECTION 3.8  Effectiveness.  This Second Supplemental Indenture shall become effective upon execution by the parties hereto.

 

[SIGNATURE PAGE FOLLOWS]

 

A-6

 

IN WITNESS WHEREOF, each of the parties hereto has caused this Second Supplemental Indenture to be duly executed on its behalf by its duly authorized officer as of the date first above written.

 

	
 
    	
CET 21 SPOL. S R.O.
    
	
 
    	
 
    
	
 
    	
By
    	
/s/ Christoph Mainusch
    
	
 
    	
 
    	
Name:
    	
Christoph Mainusch
    
	
 
    	
 
    	
Title:
    	
Executive Director
    
	
 
    	
 
    
	
 
    	
By
    	
/s/ David Sturgeon
    
	
 
    	
 
    	
Name:
    	
David Sturgeon
    
	
 
    	
 
    	
Title:
    	
Executive Director
    

 

A-7

 

	
 
    	
CENTRAL EUROPEAN MEDIA ENTERPRISES LTD.
    
	
 
    	
 
    
	
 
    	
By
    	
/s/ Christoph Mainusch
    
	
 
    	
 
    	
Name:
    	
Christoph Mainusch
    
	
 
    	
 
    	
Title:
    	
co-Chief Executive Officer
    
	
 
    	
 
    
	
 
    	
By
    	
/s/ Michael Del Nin
    
	
 
    	
 
    	
Name:
    	
Michael Del Nin
    
	
 
    	
 
    	
Title:
    	
co-Chief Executive Officer
    

 

A-8

 

	
 
    	
CENTRAL EUROPEAN MEDIA ENTERPRISES N.V.
    
	
 
    	
 
    
	
 
    	
By
    	
/s/ Daniel Penn
    
	
 
    	
 
    	
Name:
    	
Daniel Penn
    
	
 
    	
 
    	
Title:
    	
Managing Director
    

 

A-9

 

	
 
    	
CME   MEDIA ENTERPRISES B.V.
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Alphons van Spaendonck
    
	
 
    	
 
    	
Name:
    	
Alphons   van Spaendonck
    
	
 
    	
 
    	
Title:
    	
Managing   Director
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Pan-Invest B.V.
    
	
 
    	
 
    	
Name:
    	
Pan-Invest   B.V., represented by M.P.M. Schmidt-Arts
    
	
 
    	
 
    	
Title:
    	
Managing   Director
    
	
 
    	
 
    
	
 
    	
CME   INVESTMENTS B.V.
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Alphons van Spaendonck
    
	
 
    	
 
    	
Name:
    	
Alphons   van Spaendonck
    
	
 
    	
 
    	
Title:
    	
Managing   Director
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Pan-Invest B.V.
    
	
 
    	
 
    	
Name:
    	
Pan-Invest   B.V., represented by M.P.M. Schmidt-Arts
    
	
 
    	
 
    	
Title:
    	
Managing   Director
    
	
 
    	
 
    
	
 
    	
CME   SLOVAK HOLDINGS B.V.
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Alphons van Spaendonck
    
	
 
    	
 
    	
Name:
    	
Alphons   van Spaendonck
    
	
 
    	
 
    	
Title:
    	
Managing   Director
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Pan-Invest B.V.
    
	
 
    	
 
    	
Name:
    	
Pan-Invest   B.V., represented by M.P.M. Schmidt-Arts
    
	
 
    	
 
    	
Title:
    	
Managing   Director
    

 

A-10

 

	
 
    	
MARKÍZA-SLOVAKIA,   SPOL. S R.O.
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Marianna Trnavská
    
	
 
    	
 
    	
Name:
    	
Marianna   Trnavská
    
	
 
    	
 
    	
Title:
    	
Executive   Director
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Matthias Settele
    
	
 
    	
 
    	
Name:
    	
Matthias   Settele
    
	
 
    	
 
    	
Title:
    	
Executive   Director
    

 

A-11

 

	
 
    	
Signed for and on behalf of,
   CITIBANK, N.A., LONDON BRANCH, as Trustee
    
	
 
    	
 
    	
 
    
	
 
    	
By
    	
/s/ Andrew McIntosh
    
	
 
    	
 
    	
Name:
    	
 Andrew McIntosh
    
	
 
    	
 
    	
Title:
    	
 Vice President
    

 

A-12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]